DISEASE SCANNER
Global Incurable Diseases Tracker
Obesity (Class II-III)
Complex chronic disease characterized by excessive adipose tissue accumulation (BMI >=35). Associated with metabolic dysfunction, inflammation, and increased morbidity/mortality. Now recognized as relapsing-remitting disease requiring long-term management.
650.0M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1BMI calculation
- 2Waist circumference
- 3Body composition analysis
- 4Metabolic panel
- 5Sleep study (if sleep apnea suspected)
- 6Echocardiogram
- 7Psychological evaluation
Prognosis
Reduces life expectancy by 6-7 years. Increases risk: T2DM x7, hypertension x3, CAD x2, stroke x2, cancer x1.5, osteoarthritis, NAFLD. Weight loss of 5-10% improves metabolic health.
Prevention
- Healthy diet
- Regular physical activity
- Sleep hygiene
- Stress management
- Limiting processed foods
- Sugar-sweetened beverage reduction
- Early intervention in childhood
- Environmental/policy changes
Research Status
GLP-1 receptor agonists (semaglutide, tirzepatide) revolutionizing treatment with 15-22% weight loss. Dual GIP/GLP-1 agonists superior. Triple agonists (retatrutide) in trials. Metabolic/bariatric surgery most effective. Setmelanotide for genetic obesity. Gut microbiome modulation research.
Affected Countries
Sources
- https://www.cdc.gov/
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
- https://www.newbornscreening.info
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.